Oricell Therapeutics Raises Over $120 Million In Series B Financing Led By Qiming Venture Partners And Quan Capital To Advance Cell Therapies For Cancer Immunology
Amount Raised
$120 Million
Round Type
Series B
ShanghaiBiotechnologyDescription
OriCell Therapeutics (Shanghai) Co., Ltd. ("OriCell" or "the Company") has announced the completion of Series B financing totaling over US$120 million. This round of financing was jointly led by Qiming Venture Partners and Quan Capital with participation by several leading international and Chinese investment funds, as well as existing shareholder C&D Emerging Capital. The new funding will go toward the development of OriCell's cell therapy pipeline, and Company's proprietary discovery platform, as well as the construction of a manufacturing plant for both clinical and commercial purposes.
Who else raised in Biotechnology around the same time
Companies in the same sectors as OriCell Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Galvanize Therapeutics raised $100M (Series B) on September 15, 2022.
- Alphyn Biologics raised $3.3M (Series A) on September 15, 2022.
- Tridek-One raised $17M (Funding Round) on September 15, 2022.
- Carver raised an undisclosed amount (Seed) on September 15, 2022.
- TRiCares raised $47M (Series C) on September 15, 2022.
- Novome raised an undisclosed amount (Funding Round) on September 15, 2022.
Who to call at OriCell Therapeutics, and when
A new round usually means OriCell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day OriCell Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OriCell Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OriCell Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OriCell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansOriCell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.